D J Hassemer
Overview
Explore the profile of D J Hassemer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McNamara J, Leary E, Ceriotti F, Cole T, Hassemer D, Nakamura M, et al.
Clin Chem
. 1997 Aug;
43(8 Pt 1):1306-10.
PMID: 9267305
Cholesterol and triglyceride standardization procedures have been used extensively and continuously since the 1950s. Definitive and Reference Methods, as well as primary and secondary standards, have been developed and maintained...
2.
Hill B, Laessig R, Koch D, Hassemer D
Clin Chem
. 1992 Aug;
38(8 Pt 1):1474-8.
PMID: 1643717
We evaluated a plastic evacuated blood-drawing tube containing an integral serum-separating barrier gel, by direct comparison with a glass counterpart. The plastic tube demonstrated no differences when compared for common...
3.
Lanphear B, Burmeister B, Ehrmeyer S, Laessig R, Hassemer D
Clin Chem
. 1992 Jul;
38(7):1254-9; discussion 1268-72.
PMID: 1623590
Under the Clinical Laboratory Improvement Act of 1967 the Health Care Financing Administration's proficiency-testing requirement applies to approximately 12,000 hospital, reference, and large-clinic laboratories in the United States. The Wisconsin...
4.
Laessig R, Ehrmeyer S, Lanphear B, Burmeister B, Hassemer D
Clin Chem
. 1992 Jul;
38(7):1237-44; discussion 1245-50.
PMID: 1623588
Proficiency testing (PT), recognized as a quality-assurance (QA) and quality-improvement tool, also has become the cornerstone of the Health Care Financing Administration's (HCFA) regulatory strategy under the revised Clinical Laboratory...
5.
Hassemer D, Laessig R, Hoffman G, Farrell P
Pediatr Pulmonol Suppl
. 1991 Jan;
7:76-83.
PMID: 1782137
We have incorporated the IRT assay for CF to our newborn screening program, relying heavily on electronic data processing to optimize the test results in order to provide the most...
6.
Farrell P, Mischler E, Fost N, Wilfond B, Tluczek A, Gregg R, et al.
Pediatr Pulmonol Suppl
. 1991 Jan;
7:11-8.
PMID: 1782123
Many questions remain regarding the efficacy, toxicity, and costs of CF neonatal screening. It would be premature, in our opinion, to implement mass population screening of newborns for CF until...
7.
Rock M, Mischler E, Farrell P, Wei L, BRUNS W, Hassemer D, et al.
Pediatrics
. 1990 Jun;
85(6):1001-7.
PMID: 2187173
Detection of elevated levels of immunoreactive trypsinogen (IRT) in dried neonatal blood spots has been used as a screening test for cystic fibrosis. In other cystic fibrosis newborn-screening studies, a...
8.
Rock M, Mischler E, Farrell P, BRUNS W, Hassemer D, Laessig R
Pediatr Pulmonol
. 1989 Jan;
6(1):42-8.
PMID: 2704582
Blood immunoreactive trypsinogen (IRT) is elevated in newborns with cystic fibrosis (CF) and has been used as a neonatal screening test. However, not only is the benefit of early diagnosis...
9.
Koch D, Hassemer D, Wiebe D, Laessig R
JAMA
. 1988 Nov;
260(17):2552-7.
PMID: 3172430
The national emphasis on assessing coronary risk by cholesterol testing mandates that analytical determinations be as accurate and precise as is medically necessary. One goal of the National Cholesterol Education...
10.
Allen D, Hendricks S, Sieger J, Hassemer D, Katcher M, Maby S, et al.
Am J Dis Child
. 1988 Feb;
142(2):232-6.
PMID: 3341330
High-sensitivity neonatal hypothyroid screening tests are used throughout the country. Because of low specificity, primary care physicians are faced with an abundance of false-positive results that challenge the interpreting physician...